Medical Health & Life Science Research News

Discover the United States' pediatric vaccine market forecast to 2024

Discover the United States' pediatric vaccine market forecast to 2024

Growth in US pediatric vaccine market can be attributed to factors such as increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccine development.

- Agency -.

United States Pediatric Vaccine market is likely to reach nearly US$ 10 Billion by 2024.

Complete report available at www.marketreportsonline.com/682132.html.

The research report titled “United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024” examines the market dynamics, competitive landscape and discusses major trends.

- Agency -.

The study describes an in–depth analysis of the United States pediatric vaccine market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues and provides forecasts through 2024. The report also provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication.

On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccine market.

The report concludes with the profiles of major players in the United States pediatric vaccine market. The key market players are evaluated on various parameters such as company overview, pediatric vaccine portfolios and latest development & trends of the pediatric vaccine market.

Access a copy of this “Global Pediatric Vaccine Market” research report at www.marketreportsonline.com/contac…e.php?name=682132.

Key Companies Covered in the Report are as follows: Sanofi Pasteur, GlaxoSmithKline(GSK), Merck & Co., Pfizer Inc & Grifols

Key Deliverables in the Study:

Market Definition for the specified topic along with identification of key drivers and inhibitors for the market

It provides a growth map over time to understand the industry growth rate

It provides a seven-year forecast assessed based on how the market is predicted to grow

It helps in understanding the key product segments and their future

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.

Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:

  1. Diphtheria, Tetanus & Pertussis (DTap)
  2. Hepatitis A
  3. Varicella/Chicken Pox
  4. Pneumococcal
  5. Haemophilus Influenzae Type B (HIB)
  6. Polio
  7. Rotavirus
  8. Hepatitis B
  9. Influenza Pediatric
  10. Measles, Mumps & Rubella (MMR)

Major Points from Table of Contents (www.marketreportsonline.com/682132-toc.html) Provided in Global United States Pediatric Vaccine Market 2024:

  1. Executive Summary
  2. Market Size & Analysis: United States Pediatric Vaccine (2010 – 2024)
  3. United States Pediatric Vaccine Market Share and Y–o–Y Growth (%)
  4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccine Market
  5. United States Pediatric Vaccine Market – By Disease Indication (2010 – 2024)
  6. Key Companies Analysis

Few Points from List of Figures Provided in Global United States Pediatric Vaccine Market:

Figure 2–1: United States Pediatric Vaccine Market (Million US$), 2010 – 2016

Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2017 – 2024

Figure 4–19: DTap Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–20: DTap Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–21: Number of Children Being Vaccinated with DTap Vaccine (in Million),2010 – 2016

Figure 4–22: Number of Children Being Vaccinated with DTap Vaccine Forecast (in Million),2017 – 2024

Figure 4–23: DTap Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–24: DTap Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–43: Hepatitis A Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–44: Hepatitis A Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–45: Number of Children Being Vaccinated with Hepatitis A Vaccine (in Million),2010 – 2016

Figure 4–46: Number of Children Being Vaccinated with Hepatitis A Vaccine Forecast (in Million),2017 – 2024

Figure 4–47: Hepatitis A Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–48: Hepatitis A Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–49: Varicella Vaccine Doses Administered (in Million), 2010–2016

Figure 4–50: Varicella Vaccine Doses Administered Forecast (in Million), 2017 – 2024

News From

MarketReportsOnline - Industry Research Analysis StoreMarketReportsOnline
Category: Market Research Publishers and RetailersCompany profile: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.